Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 278Carcinoma, Non-Small-Cell Lung 228Prostatic Neoplasms 183Neoplasms 180Multiple Myeloma 140Lung Neoplasms 137Neoplasm Metastasis 104Colorectal Neoplasms 101Melanoma 87Ovarian Neoplasms 86Leukemia, Myeloid, Acute 78Pancreatic Neoplasms 73Lymphoma 72Leukemia, Lymphocytic, Chronic, B-Cell 67Carcinoma, Renal Cell 65Squamous Cell Carcinoma of Head and Neck 64Lymphoma, Non-Hodgkin 64Brain Neoplasms 64Recurrence 57Urinary Bladder Neoplasms 56Carcinoma, Hepatocellular 56Hematologic Neoplasms 55Head and Neck Neoplasms 55Triple Negative Breast Neoplasms 52Lymphoma, Follicular 49Glioblastoma 49Endometrial Neoplasms 48Uterine Cervical Neoplasms 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 47Sarcoma 44

Interventions

Pharmacogenomic Testing 1HhAntag691 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Chondrosarcoma, Clear Cell × 90 days × Clear all
NCT01267955 2026-04-13

Vismodegib in Treating Patients With Advanced Chondrosarcomas

National Cancer Institute (NCI)

Phase 2 Active not recruiting
45 enrolled 10 charts
Sarcoma

Chondrosarcoma, Clear Cell, Chondrosarcoma, Chondrosarcoma, Mesenchymal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡